WO2005019471A3 - Periostin-like factor: compositions and methods for making and using the same - Google Patents

Periostin-like factor: compositions and methods for making and using the same Download PDF

Info

Publication number
WO2005019471A3
WO2005019471A3 PCT/US2004/025969 US2004025969W WO2005019471A3 WO 2005019471 A3 WO2005019471 A3 WO 2005019471A3 US 2004025969 W US2004025969 W US 2004025969W WO 2005019471 A3 WO2005019471 A3 WO 2005019471A3
Authority
WO
WIPO (PCT)
Prior art keywords
plf
periostin
compositions
factor
methods
Prior art date
Application number
PCT/US2004/025969
Other languages
French (fr)
Other versions
WO2005019471A2 (en
Inventor
Judith Daniels
Original Assignee
Univ Temple
Judith Daniels
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple, Judith Daniels filed Critical Univ Temple
Publication of WO2005019471A2 publication Critical patent/WO2005019471A2/en
Publication of WO2005019471A3 publication Critical patent/WO2005019471A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Methods and compositions are provided for Periostin-Like Factor (PLF) nucleic acids and proteins and their use in diagnosing PLF associated diseases and disorders. PLF comprises a novel Periostin protein, comprising and additional peptide fragment not present in other Periostins, and lacking a peptide fragment which is present in other Periostins. PLF expression is aberrant in various diseases, and its expression appears to be important for normal embryonic development and cell differentiation.
PCT/US2004/025969 2003-08-13 2004-08-11 Periostin-like factor: compositions and methods for making and using the same WO2005019471A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49473003P 2003-08-13 2003-08-13
US60/494,730 2003-08-13

Publications (2)

Publication Number Publication Date
WO2005019471A2 WO2005019471A2 (en) 2005-03-03
WO2005019471A3 true WO2005019471A3 (en) 2005-08-04

Family

ID=34215896

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/025969 WO2005019471A2 (en) 2003-08-13 2004-08-11 Periostin-like factor: compositions and methods for making and using the same

Country Status (1)

Country Link
WO (1) WO2005019471A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101560843B1 (en) 2007-06-27 2015-10-15 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 -17 cancer remedy containing antibody against peptide encoded by exon-17 of periostin

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017119B2 (en) 2005-12-28 2011-09-13 Daiichi Sankyo Company, Ltd. Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
WO2007077934A1 (en) 2005-12-28 2007-07-12 Asubio Pharma Co., Ltd. Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
WO2009092052A2 (en) * 2008-01-18 2009-07-23 Massachusetts Eye And Ear Infirmary Methods and compositions for treating polyps
CA2736314A1 (en) * 2008-09-08 2010-03-11 Ottawa Hospital Research Institute Periostin-induced pancreatic regeneration
EP3447491A3 (en) 2010-12-16 2019-06-05 F. Hoffmann-La Roche AG Diagnosis and treatments relating to th2 inhibition
US20150184155A1 (en) * 2012-07-18 2015-07-02 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for preventing and treating chronic kidney disease (ckd)
WO2014136910A1 (en) 2013-03-08 2014-09-12 国立大学法人大阪大学 ANTIBODY TO PEPTIDE ENCODED BY Exon-21 OF PERIOSTIN, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE CONTAINING SAID ANTIBODY
CN109879963A (en) * 2019-03-15 2019-06-14 辽宁何氏医学院 A kind of monoclonal antibody and its preparation method and application for inhibiting histoorgan fibrosis and new vessels to be formed

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GILLAN L. ET AL: "Periostin secreted by epithelial ovarian carcinoma is a ligand for integrins and promotes cell motilit", CANCER RESEARCH, vol. 62, 15 September 2001 (2001-09-15), pages 5358 - 5364, XP002962758 *
KRUZYNSKA-FREJTAG A. ET AL: "Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation.", MECHANISM OF DEVELOPMENT, vol. 103, 2001, pages 183 - 188, XP002988216 *
OKAZAKI Y. ET AL: "Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs", NATURE, vol. 420, 5 December 2002 (2002-12-05), pages 563 - 574, XP001165660 *
OKAZAKI Y. ET AL: "Functional annotation of a full-length mouse of cDNA collection", NATURE, vol. 409, 8 February 2001 (2001-02-08), pages 685 - 690, XP001009930 *
SASAKI H. ET AL: "Serum level of the periostin, a homologue of an insect cell adhesion molecule, as prognostic marker in nonsmall cell lung carcinomas", CANCER, vol. 92, no. 4, 15 August 2001 (2001-08-15), pages 843 - 848, XP002962760 *
STRAUSBERG R.L. ET AL: "Generation and initial analysis of more than 15,000 full-length human and moursecDNA sequences", PNAS, vol. 99, no. 26, 24 December 2002 (2002-12-24), pages 16899 - 16903, XP002245204 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101560843B1 (en) 2007-06-27 2015-10-15 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 -17 cancer remedy containing antibody against peptide encoded by exon-17 of periostin

Also Published As

Publication number Publication date
WO2005019471A2 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
WO2001075087A3 (en) Subtilisin variants
WO2005075655A3 (en) Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
WO2002046465A3 (en) Method for identification of genes involved in specific diseases
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
ATE490309T1 (en) MUTANT E. COLI-APPA PHYTASE ZYMES AND NATURAL VARIANTS THEREOF, NUCLEIC ACIDS ENCODING SUCH PHYTASE ZYMES, VECTORS AND HOST CELLS CONTAINING THE SAME, AND METHODS FOR THE PRODUCTION AND USE THEREOF
WO2002006457A3 (en) Novel lipase genes
WO2005019471A3 (en) Periostin-like factor: compositions and methods for making and using the same
WO2001096373A3 (en) Fluorescent timer proteins and methods for their use
AU4985201A (en) Human gene critical to fertility
ATE365203T1 (en) YEAST EXTRACT SOLUTION, ITS PRODUCTION AND USE FOR CELL-FREE PROTEIN SYNTHESIS
AU2003218217A1 (en) Heterologous protein production using the twin arginine translocation pathway
WO2005018552A3 (en) Heparin binding proteins: sensors for heparin detection
AU2002220009A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2003302820A1 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
CA2384170A1 (en) Cgmp-visualizing probe and method of detecting and quantifying cgmp by using the same
WO2007005635A3 (en) Mitotic spindle protein aspm as a diagnostic marker for neoplasia and uses therefor
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
WO1998054212A3 (en) Human type 3 ryanodine receptor protein and dna molecules coding therefor
WO2002074921A3 (en) Methods for isolating proteins expressed by dendritic cells
WO2001036463A3 (en) Genes specifically expressed in human dendritic cells
WO2001053339A3 (en) Egg specific surface proteins
AU2003298029A1 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
WO2004065554A3 (en) Human saa3 nucleic acid molecule, protein, and methods of use for same
WO2006020824A3 (en) Diagnosis and treatment of kawasaki disease and coronavirus infection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase